Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Regulation of translation initiation by FRAP/mTOR.

× No keyword cloud information.

431 in total

1. Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo.

Authors: G B Mills; Y Lu; E C Kohn
Journal: Proc Natl Acad Sci U S A Date: 2001-08-28 Impact factor: 11.205

2. Hierarchical phosphorylation of the translation inhibitor 4E-BP1.

Authors: A C Gingras; B Raught; S P Gygi; A Niedzwiecka; M Miron; S K Burley; R D Polakiewicz; A Wyslouch-Cieszynska; R Aebersold; N Sonenberg
Journal: Genes Dev Date: 2001-11-01 Impact factor: 11.361

3. Translational control of SCL-isoform expression in hematopoietic lineage choice.

Authors: Cornelis F Calkhoven; Christine Muller; Richard Martin; Goradz Krosl; Hubertus Pietsch; Trang Hoang; Achim Leutz
Journal: Genes Dev Date: 2003-04-15 Impact factor: 11.361

4. Novel 5'TOPmRNAs regulated by ribosomal S6 kinase are important for cardiomyocyte development: S6 kinase suppression limits cardiac differentiation and promotes pluripotent cells toward a neural lineage.

Authors: LeeAnn Li; Shannon M Larabee; Shenglin Chen; Ladan Basiri; Seiji Yamaguchi; Asif Zakaria; G Ian Gallicano
Journal: Stem Cells Dev Date: 2012-02-08 Impact factor: 3.272

5. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1.

Authors: John H Connor; Douglas S Lyles
Journal: J Virol Date: 2002-10 Impact factor: 5.103

6. The FKBP12-rapamycin-associated protein (FRAP) is a CLIP-170 kinase.

Authors: Jae H Choi; Paula G Bertram; Ryan Drenan; John Carvalho; Heather H Zhou; X F Steven Zheng
Journal: EMBO Rep Date: 2002-09-13 Impact factor: 8.807

7. Activation of the AKT and mammalian target of rapamycin pathways and the inhibitory effects of rapamycin on those pathways in canine malignant melanoma cell lines.

Authors: Michael S Kent; Cameron J Collins; Fang Ye
Journal: Am J Vet Res Date: 2009-02 Impact factor: 1.156

8. p53 Deletion or Hotspot Mutations Enhance mTORC1 Activity by Altering Lysosomal Dynamics of TSC2 and Rheb.

Authors: Stuti Agarwal; Catherine M Bell; Shirley M Taylor; Richard G Moran
Journal: Mol Cancer Res Date: 2015-09-18 Impact factor: 5.852

9. Metastatic Renal Cancer: What Role for Everolimus?

Authors: Franck A Belibi; Charles L Edelstein
Journal: Clin Med Rev Oncol Date: 2010-02-18

10. Protein kinase C-delta and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells.

Authors: Mohd Minhajuddin; Kaiser M Bijli; Fabeha Fazal; Antonella Sassano; Keiichi I Nakayama; Nissim Hay; Leonidas C Platanias; Arshad Rahman
Journal: J Biol Chem Date: 2008-12-13 Impact factor: 5.157